BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36906172)

  • 1. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis.
    Dadashi M; Hajikhani B; Nazarinejad N; Noorisepehr N; Yazdani S; Hashemi A; Hashemizadeh Z; Goudarzi M; Fatemeh S
    J Glob Antimicrob Resist; 2023 Sep; 34():253-267. PubMed ID: 36906172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
    Kaur P; Gautam V; Tewari R
    Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
    J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.
    Bostanghadiri N; Sholeh M; Navidifar T; Dadgar-Zankbar L; Elahi Z; van Belkum A; Darban-Sarokhalil D
    Ann Clin Microbiol Antimicrob; 2024 Mar; 23(1):26. PubMed ID: 38504262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in
    Appaneal HJ; Lopes VV; LaPlante KL; Caffrey AR
    J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36306237
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis.
    Delgarm Shams-Abadi A; Mohammadian-Hafshejani A; Paterson DL; Arash R; Asadi Farsani E; Taji A; Heidari H; Shahini Shams Abadi M
    BMC Microbiol; 2023 Jul; 23(1):200. PubMed ID: 37507660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
    Junco SJ; Bowman MC; Turner RB
    Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
    Lee YL; Liu CE; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
    Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
    Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
    Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Phenotypic and Genotypic Diversity of
    Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
    Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and Antibiotic Resistance of
    Gajdács M; Urbán E
    Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole/trimethoprim a problem?
    Mendes ET; Paez JIG; Ferraz JR; Marchi AP; Silva ILAFE; Batista MV; Lima ALM; Rossi F; Levin AS; Costa SF
    Rev Inst Med Trop Sao Paulo; 2020; 62():e96. PubMed ID: 33295480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
    Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
    J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.